Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Series of microtubule-stabilizing epothilone derivatives jointly developed by BMS and GBF

Oct. 6, 2000

Kinase inhibitors and their use in the treatment of cancer, psoriasis and osteoporosis

Oct. 6, 2000

DTI-015 phase I/II clinical trials begin enrollment for treatment of glioblastoma multiforme

Oct. 6, 2000

NeoRx's skeletal targeted radiotherapy progresses to phase III

Oct. 6, 2000

Arimidex does not compromise subsequent treatment of breast cancer with tamoxifen

Oct. 6, 2000

Antileukemia immune response identified

Oct. 6, 2000

Intranasal IM-862 enters phase III

Oct. 5, 2000

Vascular-damaging combretastatin derivatives and their use in treating tumors

Oct. 5, 2000

MorphoSys and ImmunoGen begin human antibodies alliance

Oct. 5, 2000

Schering scientists disclose new antitumor epothilone derivatives

Oct. 4, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....